Skip to main content
SpringerLink
Log in

Cabergoline, prolactin and melatonin release at night in healthy men

  • Letter to the Editor
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cannavò S., Curtò L., Squadrito S., Almoto B., Vieni A., Trimarchi F. Cabergoline: a first-choice treatment in patients with previously untreated prolactin-secreting pituitary adenoma. J. Endocrinol. Invest. 1999, 22: 354–359.

    PubMed  Google Scholar 

  2. Pontiroli A.E., Cammelli L., Baroldi P., Pozza G. Inhibition of basal and metoclopramide-induced pro-lactin release by cabergoline, an extremely long-acting dopaminergic drug. J. Clin. Endocrinol. Metab. 1987, 65: 1057–1059.

    Article  CAS  PubMed  Google Scholar 

  3. Andreotti A.C., Pianezzola E., Persiani S., Pacciarini M.A., Strolin Benedetti M., Pontiroli A.E. Pharmacokinetics, pharmacodynamics, and tolera-bility of cabergoline, a prolactin-lowering drug, after administration of increasing oral doses (0.5, 1.0 and 1.5 milligrams) in healthy male volunteers. J. Clin. Endocrinol. Metab. 1995, 80: 841–845.

    CAS  PubMed  Google Scholar 

  4. Rains C., Bryson H.M., Fitton A. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and suppression of lactation. Drugs 1995, 49: 255–271.

    Article  CAS  PubMed  Google Scholar 

  5. Ferrari C., Paracchi A., Romano C., Gerevini G., Boghen M., Barreca A., Fortini P., Dubini A. Long-lasting lowering of serum growth hormone and prolactin levels by single and repetitive cabergoline administration in dopamine-responsive acromegalic patients. Clin. Endocrinol. 1998, 29: 467–476.

    Article  Google Scholar 

  6. Zimmermann R.C., Krahn L., Klee G., Delgado P., Ory S.J., Lin S.C. Inhibition of presynaptic catecholamine synthesis with α-methyl-para-tyrosine attenuates nocturnal melatonin secretion in humans. J. Clin. Endocrinol. Metab. 1994, 79: 1110–1114.

    CAS  PubMed  Google Scholar 

  7. Ial S., Isaac I., Pilapil P. Effect of apomorphine on melatonin secretion in normal subjects. Prog. Neuropsychopharmacol. Biol. Psych. 1987, 11: 229–233.

    Article  Google Scholar 

  8. Delfs T., Bispink G., Fock C., Elsen A., Zimmermenn R.C. Does dopamine mediate the interaction between melatonin and prolactin secretion? (Abstract). Proc. 47th Ann. Meeting Amer. Fertil. Soc. 1991, p. 173.

    Google Scholar 

  9. Nguyen-Legros J., Chanut E., Versaux-Botteri C., Simon A., Trouvin J.H. Dopamine inhibits melatonin synthesis in photorecep-tor cells through a D2-like receptor subtype in the rat retina: biochemical and histochemical evidence. J. Neurochem. 1996, 67: 2514–2520.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unità di Farmacologia Clinica and Unità di Malattie Metaboliche, Istituto Scientifico San Raffaele, Cattedra di Medicina Interna, Università di Milano, Italy

    M. Pacchioni, R. Camisasca, M. Caminiti, A. C. Andreotti & A. E. Pontiroli

Authors
  1. M. Pacchioni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Camisasca
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Caminiti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. C. Andreotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. E. Pontiroli
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pacchioni, M., Camisasca, R., Caminiti, M. et al. Cabergoline, prolactin and melatonin release at night in healthy men. J Endocrinol Invest 23, 135–136 (2000). https://doi.org/10.1007/BF03343693

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343693

Keywords

Search

Navigation